Drug
Pralurbactam clinical trials
Also written FL058.
- studies test it
- 6
- open now
- 3
- in phase 3
- 3
- first study started
- 2019
Keep track of what changes. Save the pralurbactam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pralurbactam is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07327619Written as Meropenem and Pralurbactam
- Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07089186Written as Meropenem and Pralurbactam
- Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAINot yet recruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT06633718Written as Meropenem and Pralurbactam
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05058118Written as FL058
- Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05058105Written as FL058 500mg and Meropenem 1000mg（ IV 120min）
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05055687Written as FL058
Codes
What other systems call pralurbactam · ClinicalTrials.gg INT016706
- UNII (FDA) GTP46AY74RPRALURBACTAMConfirmed FDA, Wikidata
- Wikidata Q140641177pralurbactamConfirmed FDA, Wikidata
- NCI Thesaurus C199094PralurbactamOne source FDA
- DrugBank DB19437One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | GTP46AY74R | PRALURBACTAM | Confirmed FDA, Wikidata |
| Wikidata | Q140641177 | pralurbactam | Confirmed FDA, Wikidata |
| NCI Thesaurus | C199094 | Pralurbactam | One source FDA |
| DrugBank | DB19437 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.